Similar weight and hemoglobin A1c improvements : Both groups improved in blood sugar and body mass index (BMI), though the non-GLP-1 group had slightly better numbers overall
The FDA's stated basis: no identified clinical need for outsourcing facilities to compound these drugs from bulk substances when FDA-approved alternatives are available
This may be of benefit for anyone with MCAS, and clinical trials are looking at the effectiveness of different doses.[ref][ref] Dementia prevention: Studies using data from diabetes patients showed a significant decrease in dementia for those on GLP-1s vs other diabetes medications
Glucagon-like peptide-1 (GLP-1) and the regulation of human invariant natural killer T cells: lessons from obesity, diabetes and psoriasis
WHO Expert Consultation: Appropriate BMI for Asian Populations
Fibromyalgia is a chronic condition characterised by widespread musculoskeletal pain, fatigue, sleep disturbances, and cognitive difficulties often referred to as 'fibro fog'